186 related articles for article (PubMed ID: 8498392)
1. Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal disease.
Allon M; Dansby L; Shanklin N
Am J Med; 1993 May; 94(5):475-482. PubMed ID: 8498392
[TBL] [Abstract][Full Text] [Related]
2. Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia.
Allon M; Takeshian A; Shanklin N
Kidney Int; 1993 Jan; 43(1):212-7. PubMed ID: 8433561
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral glucose administration on serum potassium concentration in hemodialysis patients.
Muto S; Sebata K; Watanabe H; Shoji F; Yamamoto Y; Ohashi M; Yamada T; Matsumoto H; Mukouyama T; Yonekura T; Namiki S; Kusano E
Am J Kidney Dis; 2005 Oct; 46(4):697-705. PubMed ID: 16183425
[TBL] [Abstract][Full Text] [Related]
4. Impaired extrarenal disposal of an acute oral potassium load in patients with endstage renal disease on chronic hemodialysis.
Fernandez J; Oster JR; Perez GO
Miner Electrolyte Metab; 1986; 12(2):125-9. PubMed ID: 3960016
[TBL] [Abstract][Full Text] [Related]
5. Effect of a simultaneous potassium and carbohydrate load on extrarenal K homeostasis in end-stage renal failure.
Alvo M; Krsulovic P; Fernández V; Espinoza AM; Escobar M; Marusic ET
Nephron; 1989; 53(2):133-7. PubMed ID: 2682302
[TBL] [Abstract][Full Text] [Related]
6. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.
Blumberg A; Weidmann P; Shaw S; Gnädinger M
Am J Med; 1988 Oct; 85(4):507-12. PubMed ID: 3052050
[TBL] [Abstract][Full Text] [Related]
7. Extrarenal potassium tolerance in chronic renal failure: implications for the treatment of acute hyperkalemia.
Salem MM; Rosa RM; Batlle DC
Am J Kidney Dis; 1991 Oct; 18(4):421-40. PubMed ID: 1928061
[TBL] [Abstract][Full Text] [Related]
8. Adrenergic modulation of extrarenal potassium disposal.
Rosa RM; Silva P; Young JB; Landsberg L; Brown RS; Rowe JW; Epstein FH
N Engl J Med; 1980 Feb; 302(8):431-4. PubMed ID: 6101508
[TBL] [Abstract][Full Text] [Related]
9. Adrenergic modulation of extrarenal potassium disposal in men with end-stage renal disease.
Allon M; Shanklin N
Kidney Int; 1991 Dec; 40(6):1103-9. PubMed ID: 1662320
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenergic-mediated extrarenal potassium disposal in patients with end-stage renal disease: effect of propranolol.
Yang WC; Huang TP; Ho LT; Chung HM; Chan YL; Batlle DC
Miner Electrolyte Metab; 1986; 12(3):186-93. PubMed ID: 2873504
[TBL] [Abstract][Full Text] [Related]
11. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients.
Kim HJ
Nephron; 1996; 72(3):476-82. PubMed ID: 8852501
[TBL] [Abstract][Full Text] [Related]
12. Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol.
Allon M; Shanklin N
Am J Kidney Dis; 1996 Oct; 28(4):508-14. PubMed ID: 8840939
[TBL] [Abstract][Full Text] [Related]
13. Glucose-charged dialysate for children on hemodialysis: acute dialytic changes.
Fischbach M; Terzic J; Bitoun Cohen C; Cousandier E; Hamel G; Battouche D; Geisert J
Pediatr Nephrol; 1998 Jan; 12(1):60-2. PubMed ID: 9502570
[TBL] [Abstract][Full Text] [Related]
14. Extrarenal potassium homeostasis with maximal exercise in end-stage renal disease.
Clark BA; Shannon C; Brown RS; Gervino EV
J Am Soc Nephrol; 1996 Aug; 7(8):1223-7. PubMed ID: 8866416
[TBL] [Abstract][Full Text] [Related]
15. Beta adrenergic modulation of extrarenal potassium disposal in terminal uraemia.
Martinez Vea A; Montoliu J; Andreu L; Torras A; Gaya J; López-Pedret J; Revert L
Proc Eur Dial Transplant Assoc; 1983; 19():756-60. PubMed ID: 6136035
[TBL] [Abstract][Full Text] [Related]
16. Potassium-lowering effect of albuterol for hyperkalemia in renal failure.
Montoliu J; Lens XM; Revert L
Arch Intern Med; 1987 Apr; 147(4):713-7. PubMed ID: 3827459
[TBL] [Abstract][Full Text] [Related]
17. Nonselective Beta-adrenergic blockade augments fasting hyperkalemia in hemodialysis patients.
Nowicki M; Miszczak-Kuban J
Nephron; 2002 Jun; 91(2):222-7. PubMed ID: 12053057
[TBL] [Abstract][Full Text] [Related]
18. Insulin and mineralocorticoids influence on extrarenal potassium metabolism in chronic hemodialysis patients.
Vlassopoulos D; Sonikian M; Dardioti V; Pani I; Hadjilouka-Mantaka A; Hadjiconstantinou V
Ren Fail; 2001 Nov; 23(6):833-42. PubMed ID: 11777323
[TBL] [Abstract][Full Text] [Related]
19. OACE inhibition does not interfere with acute extrarenal or renal potassium disposal in chronic renal failure.
Zwettler U; Fliser D; Nowicki M; Ritz E
Eur J Clin Pharmacol; 1994; 46(3):185-9. PubMed ID: 8070497
[TBL] [Abstract][Full Text] [Related]
20. Impairment of beta 2-adrenoceptor-stimulated potassium uptake in end-stage renal disease.
Stemmer CL; Perez GO; Oster JR
J Clin Pharmacol; 1987 Aug; 27(8):628-31. PubMed ID: 2821083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
